Soichiro Saikawa
Kashihara-shi, 6348522, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
Journal: International journal of molecular sciences
Published: August 10, 2020
Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis.
Journal: Biomedical reports
Published: March 25, 2020
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.
Journal: Antibiotics (Basel, Switzerland)
Published: March 07, 2020
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Journal: International journal of molecular sciences
Published: February 11, 2020
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 20, 2019
Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: August 20, 2019
Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study.
Journal: Nutrients
Published: August 17, 2019
Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascites.
Journal: Experimental and therapeutic medicine
Published: July 03, 2019
Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B.
Journal: Experimental and therapeutic medicine
Published: June 24, 2019
Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
Journal: International journal of molecular sciences
Published: May 14, 2019
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients.
Journal: Clinical and molecular hepatology
Published: April 04, 2019
Last Updated: 09/26/2026